Evaluation of anti-angiogenic, anti-inflammatory and antinociceptive activity of coenzyme Q10 in experimental animals

Journal of Pharmacy and Pharmacology

Volumn 61, Issue 10, 2009, Pages 1391-1395

  Jung, Hyun Joo ^a   Park, Eun Hee ^b   Lim, Chang Jin ^c  

^a Yonsei University College of Medicine   (South Korea)

^b Sookmyung Women's University   (South Korea)

^c Kangwon National University   (South Korea)

Author keywords

Anti angiogenic; Anti inflammatory; Antinociceptive; Coenzyme Q10; Mitochondria

Indexed keywords

ACETIC ACID; CARRAGEENAN; CORN OIL; DEXAMETHASONE; NITRITE; RETINOIC ACID; UBIDECARENONE; ANALGESIC AGENT; ANGIOGENESIS INHIBITOR; ANTIINFLAMMATORY AGENT; DRUG DERIVATIVE; UBIQUINONE; VITAMIN;

ABDOMINAL DISEASE; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD VESSEL PERMEABILITY; CHICK; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL ANIMAL; EXUDATE; INFLAMMATION; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; ABDOMINAL PAIN; ANGIOGENESIS; ANIMAL; CAPILLARY PERMEABILITY; CHICK EMBRYO; DISEASE MODEL; DOSE RESPONSE; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM;

ABDOMINAL PAIN; ANALGESICS; ANGIOGENESIS INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CAPILLARY PERMEABILITY; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXUDATES AND TRANSUDATES; INFLAMMATION; MALE; MICE; MICE, INBRED ICR; NEOVASCULARIZATION, PHYSIOLOGIC; NITRITES; UBIQUINONE; VITAMINS;

EID: 74949111471     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp/61.10.0017     Document Type: Article

References (27)

1. 10 from myocardial reperfusion injury during coronary artery bypass grafting. Ann Thorac Surg 1994; 58: 1427-1432.
2. Geronikaki AA, Gavalas AM. Antioxidants and inflammatory disease: synthetic and natural antioxidants with anti-inflammatory activity. Comb Chem High Throughput Screen 2006; 9: 425-442.
3. 10 on secretion levels of TNF-α and chemokines in response to LPS in the human monocytic cell line THP-1. J Clin Biochem Nutr 2009; 44: 62-66.
4. 10 in inflammation and gene expression. Biofactors 2008; 32: 179-183.
5. Bolcal C et al. Protective effects of antioxidant medications on limb ischemia reperfusion injury. J Surg Res 2007; 139: 274-279.
6. Kumar A et al. Effect of carni Q-gel (ubiquinol and carnitine) on cytokines in patients with heart failure in the Tishcon study. Acta Cardiol 2007; 62: 349-354.
7. Song YS et al. Anti-angiogenic and inhibitory activity on inducible nitric oxide production of the mushroom Ganoderma lucidum. J Ethnopharmacol 2004; 90: 17-20.
8. Whittle BA. The use of changes in capillary permeability in mice to distinguish between narcotic and nonnarcotic analgesics. Br J Pharmacol Chemother 1964; 22: 246-253.
9. Ghosh AK et al. Cyclooxygenase-2-mediated angiogenesis in carrageenan-induced granulation tissue in rats. J Pharmacol Exp Ther 2000; 295: 802-809.
10. Olajide OA et al. Studies on the anti-inflammatory, antipyretic and analgesic properties of Alstonia boonei stem bark. J Ethnopharmacol 2000; 71: 179-186.
11. Sherman MP et al. Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochem Biophys Res Commun 1993; 191: 1301-1308.
12. Mu P et al. Natural antioxidant pedicularioside G inhibits angiogenesis and tumorigenesis in vitro and in vivo. Basic Clin Pharmacol Toxicol 2007; 102: 30-34.
13. Argyriou AA et al. Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas. Oncology 2009; 77: 1-11.
14. Ishii, Y et al. Anti-angiogenic therapy on hepatocellular carcinoma development and progression. J Surg Res (accessed 24 October, 2008, epub ahead of print).
15. Quan GMY, Choong PFM. Anti-angiogenic therapy for osteosarcoma. Cancer Metast Rev 2006; 25: 707-713.
16. 10, riboflavin and niacin in breast cancer patients undergoing tamoxifen therapy. Vascul Pharmacol 2008; 48: 191-201.
17. Shono T et al. Involvement of the transcription factor NF-κB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol 1996; 16: 4231-4239.
18. Yasuda M et al. Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. Life Sci 1999; 64: 249-258.
19. Huang SS, Zheng RL. Rosmarinic acid inhibits angiogenesis and its mechanism of action in vitro. Cancer Lett 2006; 239: 271-280.
20. Nathan C. Points of control in inflammation. Nature (Lond) 2002; 420: 846-852.
21. Miles AA, Miles E. Vascular reactions to histamine, histamineliberator and leukotaxine in the skin of guinea-pigs. J Physiol 1992; 118: 228-257.
22. Bastos GNT et al. Physalis angulata extract exerts anti-inflammatory effects in rats by inhibiting different pathways. J Ethnopharmacol 2008; 118: 246-251.
23. Lechner M et al. Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Semin Cancer Biol 2005; 15: 277-289.
24. Rahman I, MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 2000; 16: 534-554.
25. Tauskela JS. MitoQ - a mitochondrial-targeted antioxidant. IDrugs 2007; 10: 399-412.
26. Lowes DA et al. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis. Free Radic Biol Med 2008; 45: 1559-1565.
27. Civenni G et al. Inhibitory effect of the neuroprotective agent idebenone on arachidonic acid metabolism in astrocytes. Eur J Pharmacol 1999; 370: 161-167.